申请人:Merz + Co. GmbH & Co.
公开号:US05061703A1
公开(公告)日:1991-10-29
A method for the prevention and treatment of cerebral ischemia using an adamantane derivative of the formula ##STR1## wherein R.sub.1 and R.sub.2 are identical or different, representing hydrogen or a straight or branched alkyl group of 1 to 6 C atoms or, in conjunction with N, a heterocyclic group with 5 or 6 ring C atoms; wherein R.sub.3 and R.sub.4 are identical or different, being selected from hydrogen, a straight or branched alkyl group of 1 to 6 C atoms, a cycloalkyl group with 5 or 6 C atoms, and phenyl; wherein R.sub.5 is hydrogen or a straight or branched C.sub.1 -C.sub.6 alkyl group, or a pharmaceutically-acceptable salt thereof, is disclosed.
使用公式##STR1##中的一种脑缺血的预防和治疗方法,其中R.sub.1和R.sub.2是相同或不同,代表氢或由1到6个碳原子的直链或支链烷基基团,或者与N结合形成具有5或6个环碳原子的杂环基团;其中R.sub.3和R.sub.4是相同或不同,选自氢、由1到6个碳原子的直链或支链烷基基团、具有5或6个碳原子的环烷基基团和苯基;其中R.sub.5是氢或直链或支链C.sub.1-C.sub.6烷基基团,或其药用可接受盐。